Denmark’s MinervaX has raised €47.4 million in a Series B funding round to take its novel group B streptococcus (GBS) vaccine into mid-stage clinical trials.

GBS Academic Requirements Students are expected to be aware of their academic standing at all times. The student is responsible for maintaining the accuracy and integrity of their academic record. We ...